Things to note before taking meloxicam and rizatriptan

Meloxicam and rizatriptan is a medicine used to treat certain types of headaches. There are a number of important things to know before considering taking this medicine.

In terms of indications, this compound tablet is mainly suitable for the treatment of acute attacks of migraine with or without aura in adult patients. However, it is not indicated for the prevention of migraines or the treatment of cluster headaches. Therefore, before taking the medicine, you must clearly diagnose whether your headache type is in line with the scope of application of the medicine.

In terms of usage precautions, this drug may interact with many medications. For example, taking it with drugs that interfere with hemostasis (such as warfarin, aspirin, etc.) may increase the risk of bleeding, especially when used with analgesic doses of aspirin, which is generally not recommended. At the same time, it may also affect the efficacy of ACE inhibitors, ARB or β receptor blockers, and blood pressure needs to be monitored when taking them. In addition, if it is combined with diuretics, lithium, methotrexate and other drugs, adverse effects may also occur. Moreover, while taking the drug, you should pay close attention to whether you have any signs of serious adverse reactions such as cardiovascular thrombotic events, arrhythmia, and cerebral hemorrhage. Once they occur, you should stop taking the drug immediately.

In terms of contraindications, the use of this drug is prohibited in patients with ischemic coronary heart disease, coronary vasospasm, cardiovascular diseases such as CABG surgery, a history of stroke or transient ischemic attack, and patients with uncontrolled hypertension, peripheral vascular disease, ischemic enteropathy, etc. At the same time, it should not be used by those who are allergic to the drug ingredients and those who have renal failure caused by insufficient blood volume or dialysis.

For special populations, such as the elderly, the clinical response may be different from that of younger people, but there is currently insufficient data to determine whether dose adjustment is needed. Pregnant and lactating women should use caution as the effects of the drug on the fetus and infant are unknown. The safety and effectiveness of the drug in children have not yet been established, and it is not recommended for children.

In short, before taking meloxicam and rizatriptan combination tablets, you must fully understand the above matters to ensure safe and reasonable use of the drugs.

Reference link:https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215431s000lbl.pdf